Clinical Trials Directory

Trials / Conditions / GEJ Adenocarcinoma

GEJ Adenocarcinoma

7 registered clinical trials studyying GEJ Adenocarcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRetlirafusp Alfa Injection Combined Chemotherapy for Perioperative Treatment of Esophagogastric Junction Adeno
NCT07493382
Tianjin Medical University Cancer Institute and HospitalN/A
RecruitingAVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
NCT07454642
Avacta Life Sciences LtdPhase 1
RecruitingA Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
NCT07182149
Normunity AccelCo, Inc.Phase 1
Not Yet RecruitingFruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037
Ruijin HospitalPhase 2
Not Yet RecruitingFruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
NCT06871527
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 1 / Phase 2
RecruitingFruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanc
NCT07334431
Henan Cancer HospitalPhase 1 / Phase 2
Active Not RecruitingTucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER
NCT04430738
Seagen, a wholly owned subsidiary of PfizerPhase 2